Please assess the completion status of the following clinical trial:

Trial Title: Nitric Oxide Administration During Pediatric Cardiopulmonary Bypass Surgery to Prevent Platelet Activation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Infants less than one year of age~* Undergoing cardiac surgery with the use of cardiopulmonary bypass~Exclusion Criteria:~* Prior surgery requiring CPB within the same hospitalization~* Pre-operative need for extracorporeal membrane oxygenation or mechanical circulatory support~* Known hypersensitivity to nitric oxide~* Known hemostatic or thrombotic disorder that results in an altered transfusion/anticoagulation protocol

- Gender: ALL
- Minimum Age: None
- Maximum Age: 1 Year
- Healthy Volunteers: f

Study Arms:
- Nitric Oxide (Type: EXPERIMENTAL): 20 ppm of Nitric Oxide delivered to the oxygenator via the INOmax device for the duration of the cardiopulmonary bypass time
- Placebo (Type: PLACEBO_COMPARATOR): INOmax device attached to the oxygenator, but no gas is delivered through the device

Based on this trial design, predict the completion outcome and termination type (if applicable).